Prokidney Forecast, price target & analysts
Prokidney Target price 2026 - Analyst rating & recommendation
Prokidney Classifications & Recommendation:
Prokidney Price Target
| Target Price | $7.14 |
| Price | $2.23 |
| Potential |
220.18%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Prokidney 2027 .
The average Prokidney target price is $7.14.
This is
220.18%
register free of charge
$12.60
465.02%
register free of charge
$1.01
54.71%
register free of charge
|
|
| A rating was issued by 14 analysts: 9 Analysts recommend Prokidney to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Prokidney stock has an average upside potential 2027 of
220.18%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.08 | 0.80 |
| 903.63% | ||
| EBITDA Margin | -216,150.00% | -19,177.29% |
| 91.13% | ||
| Net Margin | -76,487.50% | -17,786.72% |
| 76.75% |
9 Analysts have issued a sales forecast Prokidney 2025 . The average Prokidney sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Prokidney EBITDA forecast 2025. The average Prokidney EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Prokidney Analysts have issued a net profit forecast 2025. The average Prokidney net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.62 | -0.48 |
| 8.77% | 22.58% | |
| P/E | negative | |
| EV/Sales | 497.20 |
9 Analysts have issued a Prokidney forecast for earnings per share. The average Prokidney EPS is
This results in the following potential growth metrics and future valuations:
Current Prokidney Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 16 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Sep 30 2024 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 16 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 15 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jul 09 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Jun 30 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 30 2024 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 10 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
